Abstract
Clinical guidelines recommend chromosomal microarray analysis (CMA) for all children with autism spectrum disorders (ASDs). We explored the test’s perceived usefulness among parents of children with ASD who had undergone CMA, and received a result categorized as pathogenic, variant of uncertain significance, or negative. Fifty-seven parents participated in a semi-structured telephone interview, and 50 also completed a survey. Most parents reported that CMA was helpful for their child and family. Major themes regarding perceived usefulness were: medical care, educational and behavioral interventions, causal explanation, information for family members, and advancing knowledge. Limits to utility, uncertainties and negative outcomes were also identified. Our findings highlight the importance of considering both health and non-health related utility in genomic testing.
Similar content being viewed by others
References
Agency for Healthcare Research and Quality (AHRQ). (2014). Genetic testing for developmental disabilities, intellectual disability and autism spectrum disorders. (Technical Brief). Washington DC: Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services. Retrieved from http://effectivehealthcare.ahrq.gov/ehc/products/602/2024/genetic-testing-developmental-disabilities-draft-141215.pdf.
Ali-Khan, S. E., Daar, A. S., Shuman, C., Ray, P. N., & Scherer, S. W. (2009). Whole genome scanning: Resolving clinical diagnosis and management amidst complex data. Pediatric Research, 66(4), 357–363.
Battaglia, A., Doccini, V., Bernardini, L., Novelli, A., Loddo, S., Capalbo, A., & Carey, J. C. (2013). Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features. European Journal of Paediatric Neurology, 17(6), 589–599.
Bazeley, P. (2007). Qualitative analysis with Nvivo. Thousand Oaks, CA: Sage Publications Ltd.
Beaudet, A. L. (2013). The utility of chromosomal microarray analysis in developmental and behavioral pediatrics. Child Development, 84(1), 121–132.
Bernard, H. R. (2013). Social research methods: Qualitative and quantitative approaches. Thousand Oaks, CA: Sage Publications.
Biesecker, B. B., & Erby, L. (2008). Adaptation to living with a genetic condition or risk: A mini-review. Clinical Genetics, 74(5), 401–407. doi:10.1111/j.1399-0004.2008.01088.x.
Bradbury, A. R., Patrick-Miller, L., & Domchek, S. (2014). Multiplex genetic testing: Reconsidering utility and informed consent in the era of next-generation sequencing. Genetics in Medicine, 17, 97–98.
Burke, W., Laberge, A. M., & Press, N. (2010). Debating clinical utility. Public Health Genomics, 13(4), 215–223. doi:10.1159/000279623.
Carter, M., & Scherer, S. (2013). Autism spectrum disorder in the genetics clinic: A review. Clinical Genetics, 83(5), 399–407.
Chao, S., Roberts, J. S., Marteau, T. M., Silliman, R., Cupples, L. A., & Green, R. C. (2008). Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL study. Alzheimer Disease and Associated Disorders, 22(1), 94–97. doi:10.1097/WAD.0b013e31815a9dcc.
Chen, L., Xu, L., Huang, T., & Dhar, S. U. (2013). Autism genetic testing: A qualitative study of awareness, attitudes, and experiences among parents of children with autism spectrum disorders. Genetics in Medicine, 15(4), 274–281.
Condit, C. (2010). Public understandings of genetics and health. Clinical Genetics, 77(1), 1–9.
Cooper, G. M., Coe, B. P., Girirajan, S., Rosenfeld, J. A., Vu, T. H., Baker, C., et al. (2011). A copy number variation morbidity map of developmental delay. Nature Genetics, 43, 838–846.
Coulter, M. E., Miller, D. T., Harris, D. J., Hawley, P., Picker, J., Roberts, A. E., & Irons, M. (2011). Chromosomal microarray testing influences medical management. Genetics in Medicine, 13(9), 770–776.
Cuccaro, M. L., Czape, K., Alessandri, M., Lee, J., Deppen, A. R., Bendik, E., & Hahn, S. (2014). Genetic testing and corresponding services among individuals with autism spectrum disorder (ASD). American Journal of Medical Genetics Part A, 164(10), 2592–2600.
Darilek, S., Ward, P., Pursley, A., Plunkett, K., Furman, P., Magoulas, P., & Eng, C. M. (2008). Pre-and postnatal genetic testing by array-comparative genomic hybridization: Genetic counseling perspectives. Genetics in Medicine, 10(1), 13–18.
Dar-Nimrod, I., & Heine, S. J. (2011). Genetic essentialism: On the deceptive determinism of DNA. Psychological Bulletin, 137(5), 800.
Dawson, G., Rogers, S., Munson, J., Smith, M., Winter, J., Greenson, J., & Varley, J. (2010). Randomized, controlled trial of an intervention for toddlers with autism: The Early Start Denver Model. Pediatrics, 125(1), e17–e23. doi:10.1542/peds.2009-0958. Epub 2009 Nov 30.
Ellison, J. W., Ravnan, J. B., Rosenfeld, J. A., Morton, S. A., Neill, N. J., Williams, M. S., & Traylor, R. N. (2012). Clinical utility of chromosomal microarray analysis. Pediatrics, 130(5), e1085–e1095.
Eriksson, M. A., Westerlund, J., Hedvall, Å., Åmark, P., Gillberg, C., & Fernell, E. (2013). Medical conditions affect the outcome of early intervention in preschool children with autism spectrum disorders. European Child and Adolescent Psychiatry, 22(1), 23–33.
Fanos, J. H. (2012). New “first families”: The psychosocial impact of new genetic technologies. Genetics in Medicine, 14(2), 189–190.
Foster, M. W., Mulvihill, J. J., & Sharp, R. R. (2009). Evaluating the utility of personal genomic information. Genetics in Medicine, 11(8), 570–574.
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., & Ormond, K. E. (2013). ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine, 15, 565–574.
Grosse, S. D., & Khoury, M. J. (2006). What is the clinical utility of genetic testing? Genetics in Medicine, 8(7), 448–450.
Haga, S. B., Barry, W. T., Mills, R., Ginsburg, G. S., Svetkey, L., Sullivan, J., & Willard, H. F. (2013). Public knowledge of and attitudes toward genetics and genetic testing. Genetic Testing and Molecular Biomarkers, 17(4), 327–335.
Hayeems, R. Z., Hoang, N., Chenier, S., Stavropoulos, D. J., Pu, S., Weksberg, R., & Shuman, C. (2014). Capturing the clinical utility of genomic testing: Medical recommendations following pediatric microarray. European Journal of Human Genetics. doi:10.1038/ejhg.2014.260.
Hayward, D., Eikeseth, S., Gale, C., & Morgan, S. (2009). Assessing progress during treatment for young children with autism receiving intensive behavioural interventions. Autism : The International Journal of Research and Practice, 13(6), 613–633. doi:10.1177/1362361309340029.
Heil, K. M., & Schaaf, C. P. (2013). The genetics of autism spectrum disorders—A guide for clinicians. Current Psychiatry Reports, 15(1), 1–8.
Henderson, L. B., Applegate, C. D., Wohler, E., Sheridan, M. B., Hoover-Fong, J., & Batista, D. A. (2014). The impact of chromosomal microarray on clinical management: A retrospective analysis. Genetics in Medicine, 16, 657–664.
Kearney, H. M., Thorland, E. C., Brown, K. K., Quintero-Rivera, F., & South, S. T. (2011). American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genetics in Medicine, 13(7), 680–685.
Kegley, J. (2003). An ethical imperative: Genetics education for physicians and patients. Medicine and Law, 22(2), 275–283.
Khoury, M. J., McBride, C. M., Schully, S. D., Ioannidis, J. P., Feero, W. G., Janssens, A. C. J., & Cargill, M. (2010). The scientific foundation for personal genomics: Recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genetics in Medicine, 11(8), 559–567.
Lebowitz, M. S., Rosenthal, J. E., & Ahn, W. K. (2013). Effects of biological versus psychosocial explanations on stigmatization of children with ADHD. Journal of Attention Disorders. doi:10.1177/1087054712469255.
Lenhard, W., Breitenbach, E., Ebert, H., Schindelhauer-Deutscher, H. J., & Henn, W. (2005). Psychological benefit of diagnostic certainty for mothers of children with disabilities: Lessons from down syndrome. American Journal of Medical Genetics, 133A(2), 170–175. doi:10.1002/ajmg.a.30571.
Lintas, C., & Persico, A. M. (2009). Autistic phenotypes and genetic testing: State-of-the-art for the clinical geneticist. Journal of Medical Genetics, 46(1), 1–8. doi:10.1136/jmg.2008.060871.
Lipinski, S. E., Lipinski, M. J., Biesecker, L. G., & Biesecker, B. B. (2006). Uncertainty and perceived personal control among parents of children with rare chromosome conditions: The role of genetic counseling. American Journal of Medical Genetics, Part C: Seminars in Medical Genetics, 142(4), 232–240. doi:10.1002/ajmg.c.30107.
Makela, N. L., Birch, P. H., Friedman, J. M., & Marra, C. A. (2009). Parental perceived value of a diagnosis for intellectual disability (ID): A qualitative comparison of families with and without a diagnosis for their child’s ID. American Journal of Medical Genetics. Part A, 149A(11), 2393–2402. doi:10.1002/ajmg.a.33050.
Manning, M., & Hudgins, L. (2010). Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genetics in Medicine, 12(11), 742–745. doi:10.1097/GIM.0b013e3181f8baad.
McMahon, W. M., Baty, B. J., & Botkin, J. R. (2006). Genetic counseling and ethical issues for autism. American Journal of Medical Genetics - Seminars in Medical Genetics, 142(1), 52–57. doi:10.1002/ajmg.c.30082.
Mefford, H. C., Batshaw, M. L., & Hoffman, E. P. (2012). Genomics, intellectual disability, and autism. New England Journal of Medicine, 366(8), 733–743.
Miles, M. B., & Huberman, A. M. (1994). Qualitative data analysis: An expanded sourcebook (2nd ed.). Thousand Oaks, CA: Sage.
Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N. P., & Epstein, C. J. (2010a). Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. The American Journal of Human Genetics, 86(5), 749–764.
Miller, F. A., Hayeems, R. Z., & Bytautas, J. P. (2010b). What is a meaningful result? Disclosing the results of genomic research in autism to research participants. European Journal of Human Genetics, 18(8), 867–871.
Narcisa, V., Discenza, M., Vaccari, E., Rosen-Sheidley, B., Hardan, A. Y., & Couchon, E. (2012). Parental interest in a genetic risk assessment test for autism spectrum disorders. Clinical Pediatrics, 52(2), 139–146.
Redon, R., Ishikawa, S., Fitch, K. R., Feuk, L., Perry, G. H., Andrews, T. D., & Hurles, M. E. (2006). Global variation in copy number in the human genome. Nature, 444(7118), 444–454. doi:10.1038/nature05329.
Regier, D., Friedman, J., Makela, N. L., Ryan, M., & Marra, C. (2009). Valuing the benefit of diagnostic testing for genetic causes of idiopathic developmental disability: Willingness to pay from families of affected children. Clinical Genetics, 75(6), 514–521.
Reiff, M., Bernhardt, B. A., Mulchandani, S., Soucier, D., Cornell, D., Pyeritz, R. E., & Spinner, N. B. (2012). “What does it mean?”: Uncertainties in understanding results of chromosomal microarray testing. Genetics in Medicine, 14(2), 250–258.
Reiff, M., & Mulchandani, S. (2015). Integrating genetics into healthcare: Implications of genomic testing for individuals with autism spectrum disorders. In E. Giarelli, & K. Fisher (Eds.), Integrated healthcare for people with autism spectrum disorders: Interdisciplinary planning and delivery of care. Springfield, IL: Charles C. Thomas, Publishers, Ltd.
Reiff, M., Ross, K., Mulchandani, S., Propert, K. J., Pyeritz, R. E., Spinner, N. B., & Bernhardt, B. A. (2013). Physicians’ perspectives on the uncertainties and implications of chromosomal microarray testing of children and families. Clinical Genetics, 83(1), 23–30.
Riggs, E. R., Wain, K. E., Riethmaier, D., Smith-Packard, B., Faucett, W., Hoppman, N., & Miller, D. T. (2014). Chromosomal microarray impacts clinical management. Clinical Genetics, 85(2), 147–153.
Roberts, J. L., Hovanes, K., Dasouki, M., Manzardo, A. M., & Butler, M. G. (2014). Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic services. Gene, 535(1), 70–78.
Rosas-Blum, E., Shirsat, P., & Leiner, M. (2007). Communicating genetic information: A difficult challenge for future pediatricians. BMC Medical Education, 7(1), 17.
Rossi, J., Newschaffer, C., & Yudell, M. (2013). Autism spectrum disorders, risk communication, and the problem of inadvertent harm. Kennedy Institute of Ethics Journal, 23(2), 105–138.
Sasson, N. J., Lam, K., Parlier, M., Daniels, J. L., & Piven, J. (2013). Autism and the broad autism phenotype: Familial patterns and intergenerational transmission. Journal of Neurodevelopmental Disorders, 5(1), 11.
Schaefer, G. B., & Mendelsohn, N. J. (2013). Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genetics in Medicine, 15(5), 399–407.
Scherer, S. W., & Dawson, G. (2011). Risk factors for autism: Translating genomic discoveries into diagnostics. Human Genetics, 130(1), 123–148.
Selkirk, C. G., McCarthy Veach, P., Lian, F., Schimmenti, L., & Leroy, B. S. (2009). Parents’ perceptions of autism spectrum disorder etiology and recurrence risk and effects of their perceptions on family planning: Recommendations for genetic counselors. Journal of Genetic Counseling, 18(5), 507–519. doi:10.1007/s10897-009-9233-0.
Shen, Y., Dies, K. A., Holm, I. A., Bridgemohan, C., Sobeih, M. M., Caronna, E. B., & Miller, D. T. (2010). Clinical genetic testing for patients with autism spectrum disorders. Pediatrics, 125(4), e727–e735. doi:10.1542/peds.2009-1684.
Shen, J., Lincoln, S., & Miller, D. T. (2014). Advances in Genetic Discovery and Implications for Counseling of Patients and Families with Autism Spectrum Disorders. Current Genetic Medicine Reports, 2(3), 124–134.
Shen, J., & Miller, D. T. (2014). Advances in genetic diagnosis of autism spectrum disorders. Current Pediatrics Reports, 2(2), 71–81.
Tabor, H. K., & Cho, M. K. (2007). Ethical implications of array comparative genomic hybridization in complex phenotypes: Points to consider in research. Genetics in Medicine, 9(9), 626–631. doi:10.1097/GIM.0b013e3181485688.
Talkowski, M. E., Minikel, E. V., & Gusella, J. F. (2014). Autism spectrum disorder genetics: Diverse genes with diverse clinical outcomes. Harvard Review of Psychiatry, 22(2), 65–75.
Trottier, M., Roberts, W., Drmic, I., Scherer, S. W., Weksberg, R., Cytrynbaum, C., & Miller, F. A. (2013). Parents’ perspectives on participating in genetic research in autism. Journal of Autism and Developmental Disorders, 43(3), 556–568.
Turbitt, E., Halliday, J., Amor, D., & Metcalfe, S. (2014). Preferences for results from genomic microarrays: Comparing parents and health care providers. Clinical Genetics, 87, 21–29.
Veenstra-VanderWeele, J., Christian, S. L., & Cook, E. H. (2004). Autism as a paradigmatic complex genetic disorder. Annual Review of Genomics and Human Genetics, 5, 379–405. doi:10.1146/annurev.genom.5.061903.180050.
Walsh, P., Elsabbagh, M., Bolton, P., & Singh, I. (2011). In search of biomarkers for autism: Scientific, social and ethical challenges. Nature Reviews Neuroscience, 12(10), 603–612.
Warren, Z., McPheeters, M. L., Sathe, N., Foss-Feig, J. H., Glasser, A., & Veenstra-VanderWeele, J. (2011). A systematic review of early intensive intervention for autism spectrum disorders. Pediatrics, 127(5), e1303–e1311. doi:10.1542/peds.2011-0426.
Yudell, M., Tabor, H. K., Dawson, G., Rossi, J., Newschaffer, C. J., & Working Group in Autism Risk Communication and Ethics. (2013). Priorities for autism spectrum disorder risk communication and ethics. Autism: The International Journal of Research and Practice, 17(6), 701–722. doi:10.1177/1362361312453511.
Acknowledgments
The authors wish to thank Rena Vanzo of Lineagen Inc. for assistance with recruitment, and all the parents for their participation in the study. This research was supported by a Grant from the National Human Genome Research Institute of the National Institutes of Health. Preliminary results for this paper were presented at the American College of Medical Genetics Annual Meeting, New Orleans (2014).
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical standard
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reiff, M., Giarelli, E., Bernhardt, B.A. et al. Parents’ Perceptions of the Usefulness of Chromosomal Microarray Analysis for Children with Autism Spectrum Disorders. J Autism Dev Disord 45, 3262–3275 (2015). https://doi.org/10.1007/s10803-015-2489-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10803-015-2489-3